ArticleJournal of Cancer2019

Combined Therapy Sensitivity Index Based on a 13-Gene Signature Predicts Prognosis for IDH Wild-type and MGMT Promoter Unmethylated Glioblastoma Patients.

Ningrong Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.